Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay

Pancreas

Volumn 17, Issue 4, 1998, Pages 341-347

  Watanabe, Hiroyuki ^a   Yamaguchi, Yasushi ^a   Ha, Aiguli ^a   Hu, Yu Xin ^a   Motoo, Yoshiharu ^a   Okai, Takashi ^a   Yoshimura, Tadashi ^b   Sawabu, Norio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b Chugai Diagnostics Science Co Ltd   (Japan)

Author keywords

K ras mutations at codon 12; Pancreatic cancer; Pancreatic juice; PCR HPA (hybridization protection assay); Quantitative measurement

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; MALE; ONCOGENE K RAS; PANCREAS CANCER; PANCREAS JUICE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0031794158     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199811000-00004     Document Type: Article

References (28)

1. Nakaizumi A, Tatsuta M, Uehara H, et al. Cytologic examination of pure pancreatic juice in the diagnosis of pancreatic carcinoma. Cancer 1992;70:2610-4.
2. Kameya S, Kuno N, Kasugai T. The diagnosis of pancreatic cancer by pancreatic juice cytology. Acta Cytol 1981;25:354-60.
3. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53:549-54.
4. Smit VTHBM, Boot AJM, Fleuren GJ, Cornelisse CJ, Bos JL. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acid Res 1988;16:7773-82.
5. Grünewald K, Lyons J, Fröhlich A, et al. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 1989;43:1037-41.
6. Mariyama M, Kishi K, Nakamura K, Obata H, Nishimura S. Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients. Jpn J Cancer Res 1989;80:622-6.
7. Nagata Y, Abe M, Motoshima K, Nakayama E, Shiku H. Frequent glycine-to-aspartic acid mutations at codon 12 of c-Ki-ras gene in human pancreatic cancer in Japanese. Jpn J Cancer Res 1990;81: 135-40.
8. Tada M, Omata M, Ohio M. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology 1991;100:233-8.
9. Rail CJN, Yan YX, Graeme-Cook F, et al. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma. Pancreas 1996;12: 10-7.
10. Watanabe H, Sawabu N, Ohta H, et al. Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers. Jpn J Cancer Res 1993;84:961-5.
11. Watanabe H, Sawabu N, Songür Y, et al. Detection of K-ras point mutations at codon 12 in pure pancreatic juice for the diagnosis of pancreatic cancer by PCR-RFLP analysis. Pancreas 1996;12:18-24.
12. Tada M, Omata M, Kawai S, et al. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 1993;53:2472-4.
13. Miki H, Matsumoto S, Harada H, et al. Detection of c-Ki-ras point mutation from pancreatic juice. Int J Pancreatol 1993;14:145-8.
14. Kondo H, Sugano K, Fukayama N, et al. Detection of point mutation in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer 1994;73:1589-94.
15. Berthélemy P, Bouisson M, Escourrou J, Vaysse N, Rumeau JL, Pradayrol L. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 1995; 123:188-91.
16. Yanagisawa A, Ohtake K, Ohhashi K, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993;53:953-6.
17. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 1994;54:3568-73.
18. Tada M, Kawabe T, Omata M. Diagnosis of pancreatic carcinoma by oncogene. Kan-Tan-Sui 1995;30:609-14 (in Japanese).
19. Arnold LJ, Hammond PW, Wiese WA, Nelson NC. Assay formats involving acridinium-ester-labeled DNA probes. Clin Chem 1989; 35:1588-94.
20. Watanabe H, Miyagi C, Yamaguchi Y, et al. Detection of K-ras point mutations at codon 12 in pancreatic juice for the diagnosis of pancreatic cancer by hybridization protection assay: a simple method for the determination of the types of point mutations. Jpn J Cancer Res 1996;87:466-74.
21. Clinical, surgical, and comprehensive findings. In: Japan Pancreas Society, ed. Classification of pancreatic carcinoma. (First English Edition). Tokyo: Kanehara Co., 1996:2-14.
22. Homma T, Harada H, Koizumi M. Diagnostic criteria for chronic pancreatitis by the Japan Pancreas Society. Pancreas 1997;15: 14-5.
23. Lerman LS. The structure of the DNA-acridine complex. Proc Natl Acad Sci USA 1963;49:94-102.
24. Asseline U, Delarue M, Lancelot G, et al. Nucleic acid-binding molecules with high affinity and base sequence specificity: intercalating agents covalently linked to oligodeoxynucleotides. Proc Natl Acad Sci USA 1984;81:3297-301.
25. Cieplak P, Rao SN, Hélène C. Montenay-Garestier T, Kollman PA. Conformation of duplex structures formed by oligodeoxynucleotides covalently linked to the intercalator 2-methoxy-6-chloro-9-aminoacridine. J Biomol Struct Dyn 1987;5:361-82.
26. Motoo Y, Kawakami H, Watanabe H, et al. Serum sialyl-Tn antigen levels in patients with digestive cancers. Oncology 1991;48: 321-6.
27. Capella G, Cronauer-Mitra S, Peinado MA, Perucho M. Frequency and spectrum of mutations at codon 12 and 13 of the c-K-ras gene in human tumors. Environ Health Perspect 1991;93:125-31.
28. Hruban RH, Mansfeld ADM, Offerhaus GJA, et al. K-ras oncogene activation in adenocarcinoma of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143:545-54.